Gerald David Weinstein
#157,762
Most Influential Person Now
Gerald David Weinstein's AcademicInfluence.com Rankings
Gerald David Weinsteinphilosophy Degrees
Philosophy
#8974
World Rank
#12462
Historical Rank
Logic
#5982
World Rank
#7449
Historical Rank
Download Badge
Philosophy
Gerald David Weinstein's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biomedical Sciences University of California, San Francisco
Why Is Gerald David Weinstein Influential?
(Suggest an Edit or Addition)Gerald David Weinstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. (2007) (509)
- Methotrexate in psoriasis: consensus conference. (1998) (355)
- Methotrexate in psoriasis: revised guidelines. (1988) (327)
- Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. (2009) (315)
- Abnormal cell proliferation in psoriasis. (1968) (292)
- Treatment of psoriasis. (1976) (288)
- A randomized trial of etanercept as monotherapy for psoriasis. (2003) (256)
- Autoradiographic analysis of turnover times of normal and psoriatic epidermis. (1965) (244)
- Methotrexate for psoriasis. A new therapeutic schedule. (1971) (240)
- Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? (2000) (234)
- Topical tretinoin for treatment of photodamaged skin. A multicenter study. (1991) (233)
- Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. (2004) (228)
- Methotrexate guidelines--revised. (1982) (224)
- Psoriasis-liver-methotrexate interactions. (1973) (211)
- Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. (1997) (191)
- Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. (1998) (188)
- Hormonal effect on psoriasis in pregnancy and post partum. (2005) (175)
- Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. (1997) (171)
- Cell proliferation in normal epidermis. (1984) (165)
- Cell kinetic basis for pathophysiology of psoriasis. (1985) (154)
- The ichthyosiform dermatoses. II. Autoradiographic studies of epidermal proliferation. (1966) (152)
- Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. (2001) (145)
- PARENTERAL METHOTREXATE IN PSORIASIS. (1964) (141)
- Consensus workshop on the toxic effects of long-term PUVA therapy. (1998) (134)
- Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. (1997) (131)
- An approach to the treatment of moderate to severe psoriasis with rotational therapy. (1993) (128)
- Drugs Five Years Later: Methotrexate (1977) (124)
- From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. (2008) (120)
- Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. (2005) (119)
- Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. (1991) (118)
- Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. (2003) (118)
- Psoriasis: current perspectives with an emphasis on treatment. (1999) (112)
- Phototoxic potential of minocycline and doxycycline. (1972) (102)
- Cell proliferation in human basal cell carcinoma. (1970) (98)
- Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo. (1970) (95)
- Location of proliferating cells in human epidermis. (1970) (93)
- Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. (2001) (88)
- Topical administration of Vitamin A acid for ichthyosiform dermatoses and psoriasis. (1969) (88)
- Collagen and elastin of human dermis. (1960) (85)
- Use of methotrexate in psoriasis. (1972) (82)
- AUTORADIOGRAPHIC STUDIES ON TURNOVER TIME AND PROTEIN SYNTHESIS IN PIG EPIDERMIS. (1965) (78)
- Methotrexate. Mechanism of action on DNA synthesis in psoriasis. (1971) (74)
- Prostaglandin and DNA synthesis in human skin: possible relationship to ultraviolet light effects. (1975) (71)
- Autoradiographic analysis of cell proliferation kinetics in human genital tissues. I. Normal cervix and vagina. (1970) (71)
- Ichthyosiform dermatoses. 3. Studies of transepidermal water loss. (1968) (69)
- Cell proliferation kinetics in benign and malignant skin diseases in humans. (1969) (68)
- Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light. (1977) (66)
- Topical methotrexate therapy for psoriasis. (1989) (64)
- Eye changes in ichthyosis. (1968) (62)
- treatment of psoriasis (1976) (61)
- ‘Keratolytic’ Properties of Benzoyl Peroxide and Retinoic Acid Resemble Salicylic Acid in Man (2006) (61)
- An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. (2003) (59)
- Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. (1996) (57)
- Cell proliferation kinetics in the human hair root. (1980) (55)
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. (1998) (55)
- Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies. (1997) (55)
- Factors affecting human percutaneous penetration of methotrexate and its analogues in vitro. (1976) (52)
- Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative (1984) (52)
- The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. (1998) (51)
- Treatment of ichthyosis with isotretinoin. (1982) (51)
- Localized epidermolytic hyperkeratosis. A form of keratoderma of the palms and soles. (1970) (50)
- BIOCHEMICAL and PATHOPHYSIOLOGICAL RATIONALE for AMETHOPTERIN in PSORIASIS * (1971) (49)
- Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. (1970) (46)
- Cytotoxic and immunologic effects of methotrexate in psoriasis. (1990) (46)
- Kinetics of human epidermal cell proliferation: diurnal variation. (1968) (44)
- Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo. (1979) (42)
- In vitro interconversion of estrone and 17-beta-estradiol in human skin and vaginal mucosa. (1968) (42)
- Hypercalcemia associated with oral isotretinoin in the treatment of severe acne. (1983) (42)
- Cytokinetics in diseases of epidermal hyperplasia. (1973) (41)
- The treatment of severe psoriasis. A national survey. (1987) (40)
- Methacycline and demeclocycline in relation to sunlight. (1971) (39)
- Therapy of Moderate-to-Severe-Psoriasis, Second Edition (2003) (39)
- A systemic type I 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris (2004) (38)
- Ultraviolet light and tar in the Goeckerman treatment of psoriasis. (1976) (36)
- Tazarotene gel: efficacy and safety in plaque psoriasis. (1997) (36)
- Epidermal activity in annular dermatophytosis. (1976) (35)
- A clinical screening program for topical chemotherapeutic drugs in psoriasis. (1981) (35)
- Selective action of methotrexate on psoriatic epidermal cells. (1972) (33)
- Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications. (1997) (32)
- Methotrexate and psoriasis: consensus conference. (2011) (32)
- Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors. (2003) (30)
- Biodynamic studies of hamster flank organ growth: hormonal influences. (1973) (30)
- Estrogen and the skin. (2006) (27)
- A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. (2004) (25)
- Metabolism of progesterone-4-14C in vitro in human skin and vaginal mucosa. (1969) (25)
- Ro 20-1724: an agent that significantly improves psoriatic lesions in double-blind clinical trials. (1979) (25)
- Development of a topical hematoporphyrin derivative formulation: characterization of photosensitizing effects in vivo. (1983) (24)
- Systemic Chemotherapy For Psoriasis: A National Survey (1976) (24)
- Percutaneous absorption of methotrexate: effect on epidermal DNA synthesis in hairless mice. (1982) (23)
- Inflammatory neovascular nodules associated with oral isotretinoin treatment of severe acne. (1983) (23)
- Quantitative determination of griseofulvin by a spectrophotofluorometric assay. (1960) (22)
- Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and Eczema (1985) (22)
- Gynecologic uses of photoradiation therapy. (1984) (22)
- Metabolism of estradiol-17β and estrone in human skin. (1966) (21)
- Moderate-to-Severe Psoriasis (2008) (21)
- Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and Eczema (1985) (21)
- Topical drug effects on normal and proliferating epidermal cell models. (1981) (21)
- Cytokinetics and chemotherapy of psoriasis. (1976) (21)
- Methotrexate and other chemotherapeutic agents used to treat psoriasis. (1995) (20)
- Epithelial neoplasms (1974) (19)
- THE METABOLISM OF COUMARIN BY A MICROORGANISM. II. THE REDUCTION OF O-COUMARIC ACID TO MELILOTIC ACID. (1964) (18)
- Effectiveness of topical therapy for psoriasis: results of a national survey. (1995) (18)
- Biological and biochemical actions of methotrexate in psoriasis. (1978) (18)
- Androgenic regulation of nucleic acid and protein synthesis in the hamster flank organ and other tissues. (1971) (18)
- New model of a scaling dermatosis: induction of hyperproliferation in hairless mice with eicosa-5,8,11-trienoic acid. (1981) (17)
- Commentary: three decades of folic acid antagonists in dermatology. (1983) (17)
- Syndrome of unilateral ectromelia, psoriasis and central nervous system anomalies. (1971) (15)
- Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea. (2009) (15)
- ON THE CELL CYCLE OF PSORIASIS (1975) (14)
- Cell kinetics of human sebaceous glands. (1974) (14)
- Effects of methotrexate esters on normal and psoriatic skin. (1975) (12)
- Can immunomodulatory molecules work topically for psoriasis? (1996) (11)
- Methotrexate for psoriasis. (1973) (10)
- Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea. (2010) (10)
- Effect of lipid-soluble esters of methotrexate on DNA synthesis in human skin. (1974) (9)
- Treatment of psoriasis with piritrexim, a lipid-soluble folate antagonist. (1991) (9)
- An Overview of Psoriasis (2008) (8)
- PHOTOSENSITIZERS IN DERMATOLOGY * (1987) (8)
- In vitro screening of biochemical activity of folic acid antagonists in skin. (1977) (8)
- Diagnosis of Lesch-Nyhan syndrome by direct study of skin specimens. (1970) (8)
- Mouse vaginal assay for topically effective chemotherapeutic agents. (1975) (7)
- Infliximab in the Treatment of Psoriasis (2003) (7)
- Immunobiologicals for Psoriasis: Using Targeted Immunotherapies as Pathogenic Probes in Psoriasis (2003) (7)
- Possible role of prostaglandins (PGs) in scaly dermatosis. (1981) (7)
- Occupational ultraviolet light and skin disease. Two case reports. (1963) (7)
- The role of cell kinetics in the chemotherapy of hyperproliferative skin diseases. (1979) (7)
- Regulation of epidermal proliferation in mouse epidermis by combination of difluoromethyl ornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG). (1985) (6)
- Chemotherapy for Psoriasis (1984) (6)
- Metabolism of Coumarin by a Micro-organism (1964) (5)
- Erratum: Proceedings of the psoriasis combination and rotation therapy conference (Journal of the American Academy of Dermatology (1996) 34 (315- 321)) (1996) (5)
- Systemic chemotherapy for psoriasis: a national survey. (1976) (5)
- Psoriasis therapy after remission: the next step (1997) (5)
- Hair roots of the human scalp in thyroid disease. (1959) (5)
- Percutaneous penetration of methylglyoxal bis(guanylhydrazone): effects on hairless mouse epidermis in vivo. (1983) (4)
- General Guidelines for Administration of Topical Agents in the Treatment of Mild-to-Moderate Psoriasis (2006) (4)
- Managing psoriasis. (1972) (3)
- Mechanism of chemotherapeutic drug action in mouse vaginal epithelium. (1981) (3)
- Topical tritiated thymidine for epidermal growth fraction determination. (1986) (3)
- Etanercept for Treatment of Psoriasis and Psoriatic Arthritis (2003) (3)
- Contact Allergy to Tylosin (1976) (2)
- Photodynamic therapy of patients having multiple actinic keratoses with topical 5-aminolevulinic acid (ALA) and non-laser blue light (1998) (2)
- The use and abuse of immunosuppressive agents in dermatology. (1985) (2)
- Topical hematoporphyrin derivative (HPD) photodynamic therapy for psoriasis (1988) (2)
- Cutaneous photosensitization by topical hematoporphyrin derivative formulations; potential clinical applications (1983) (2)
- The action of antimetabolites in the skin: methotrexate for psoriasis. (1972) (2)
- Mechanism of Chemotherapeutic Drug Action in Mouse Vaginal Epithelium: Predictive Value for Topical Antipsoriatic Drugs (1981) (2)
- Identification of Differentiation‐Specific Antigens in Psoriatic Versus Normal Skin Using Monoclonal Antibodies (1988) (2)
- Letter: Contact allergy to tylosin. (1976) (1)
- The management of psoriasis-tazarotene: the bottom line. (1998) (1)
- Oral and topical cyclosporine therapy for psoriasis. (1989) (0)
- Percutaneous penetration of methylglyoxal bis (guanylhydrazone) and evaluation of topical formulation in hairless mouse model (1982) (0)
- Psoriasis workshop : molecular, immunologic and pharmacologic aspects of psoriasis : Deer Valley, UT, September 14-17, 1989 (1990) (0)
- Cell Proliferation in Human Basal Cell Carcinoma 1 (2006) (0)
- Means for increasing the skin penetration of pharmacologically active compounds. (1988) (0)
- Molecular, immunologic, and pharmacologic aspects of psoriasis: Preface (1990) (0)
- Oral Retinoids IN THE PAST DECADE (2004) (0)
- Iconography : Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis (2011) (0)
- Vasoactive pharmacologic responses of human skin xenografts in ciclosporin-treated rats. (1989) (0)
- Letter: On the cell cycle of psoriasis. (1975) (0)
- METHOD AND COMPOST ONS FOR ENHANCNG THE CUTANEOUS PENETRATION OF PHARMACOLOGICALLY ACTIVE AGENTS (2017) (0)
- Update on drugs used in the treatment of psoriasis (2001) (0)
- Cell Proliferation in Nor mal Epidermis * (2010) (0)
- Specificity of Human Keratinocyte X HeLa Cell Hybrid Murine Monoclonal Antibodies (1991) (0)
- Cytotoxic and immunologic effects of methotrexate in psoriasis. (1990) (0)
This paper list is powered by the following services:
